Improving vaccine efficacy against malignant glioma-Reference-Cited by-同舟云学术

Improving vaccine efficacy against malignant glioma

Published:2016-06-10 Issue:8 Volume:5 Page:e1196311
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Ladomersky Erik,Genet Matthew,Zhai Lijie,Gritsina Galina,Lauing Kristen L.,Lulla Rishi R.,Fangusaro Jason,Lenzen Alicia,Kumthekar Priya,Raizer Jeffrey J.,Binder David C.,James C. David,Wainwright Derek A.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1196311

Reference119 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

2. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

3. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions

4. Epidemiology of Gliomas

5. Malignant Gliomas in Adults

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-09-11

2. Preclinical support for tumor protein D52 as a cancer vaccine antigen;Human Vaccines & Immunotherapeutics;2023-10-30

3. Regulation of Redox Profile and Genomic Instability by Physical Exercise Contributes to Neuroprotection in Mice with Experimental Glioblastoma;Antioxidants;2023-06-26

4. Regulation of redox profile and genomic stability by physical exercise contributes to neuroprotection in mice with experimental glioblastoma.;2023-03-23

5. The immunosuppressive microenvironment and immunotherapy in human glioblastoma;Frontiers in Immunology;2022-11-17